Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for EYPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 180.47M
March 31, 2026 222.54M
December 31, 2025 306.09M
September 30, 2025 204.02M
June 30, 2025 255.73M
March 31, 2025 318.19M
December 31, 2024 370.91M
September 30, 2024 253.79M
June 30, 2024 280.25M
March 31, 2024 299.35M
December 31, 2023 331.05M
September 30, 2023 136.01M
June 30, 2023 142.54M
March 31, 2023 122.48M
December 31, 2022 144.56M
September 30, 2022 157.26M
June 30, 2022 171.17M
March 31, 2022 190.78M
December 31, 2021 211.56M
September 30, 2021 119.71M
June 30, 2021 127.63M
March 31, 2021 138.58M
December 31, 2020 44.91M
September 30, 2020 28.73M
June 30, 2020 22.81M
Date Value
March 31, 2020 26.30M
December 31, 2019 22.21M
September 30, 2019 31.76M
June 30, 2019 44.16M
March 31, 2019 43.38M
December 31, 2018 45.26M
September 30, 2018 55.76M
June 30, 2018 38.78M
March 31, 2018 16.35M
June 30, 2017 16.90M
March 31, 2017 15.37M
December 31, 2016 17.53M
September 30, 2016 22.55M
June 30, 2016 28.99M
March 31, 2016 33.27M
December 31, 2015 21.09M
September 30, 2015 24.00M
June 30, 2015 28.54M
March 31, 2015 31.66M
December 31, 2014 35.69M
September 30, 2014 14.31M
June 30, 2014 18.28M
March 31, 2014 21.27M
December 31, 2013 15.72M
September 30, 2013 16.45M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ocular Therapeutix, Inc. 598.64M
Eli Lilly & Co. 8.95B
Elanco Animal Health, Inc. 530.00M
Amylyx Pharmaceuticals, Inc. 250.76M
Nuvation Bio, Inc. 660.96M